Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. (2020)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(20)30366-0
PubMed Identifier: 32861275
Publication URI: http://europepmc.org/abstract/MED/32861275
Type: Journal Article/Review
Volume: 8
Parent Publication: The Lancet. Respiratory medicine
Issue: 12
ISSN: 2213-2600